Walvax BioTech Net Asset Quality Index
Walvax BioTech net asset quality index. Walvax BioTech (300142) has a Net Asset Quality Index of 69.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.50 Billion minus total liabilities of CN¥3.17 Billion yields net assets of CN¥7.33 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Walvax BioTech (300142) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Walvax BioTech (2007–2025)
Net asset quality index of Walvax BioTech from 2007 to 2025. This chart shows how Walvax BioTech's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 69.8%, representing net assets of CN¥7.33 Billion against total assets of CN¥10.50 Billion CNY. See Walvax BioTech net assets for net asset value and shareholders' equity analysis.
Walvax BioTech Net Asset Quality Index by Year (2007–2025)
Walvax BioTech net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Walvax BioTech from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Walvax BioTech market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.3% | CN¥9.81 Billion | CN¥12.07 Billion | CN¥2.26 Billion | ▲ +3.1 pp |
| 2024 | 78.2% | CN¥11.51 Billion | CN¥14.72 Billion | CN¥3.22 Billion | ▲ +5.1 pp |
| 2023 | 73.1% | CN¥11.40 Billion | CN¥15.59 Billion | CN¥4.19 Billion | ▲ +1.4 pp |
| 2022 | 71.7% | CN¥10.99 Billion | CN¥15.34 Billion | CN¥4.35 Billion | ▼ -1.5 pp |
| 2021 | 73.1% | CN¥10.00 Billion | CN¥13.67 Billion | CN¥3.68 Billion | ▼ -8.2 pp |
| 2020 | 81.3% | CN¥7.85 Billion | CN¥9.65 Billion | CN¥1.80 Billion | ▲ +0.6 pp |
| 2019 | 80.7% | CN¥5.67 Billion | CN¥7.02 Billion | CN¥1.35 Billion | ▲ +8.1 pp |
| 2018 | 72.6% | CN¥5.26 Billion | CN¥7.24 Billion | CN¥1.98 Billion | ▲ +12.1 pp |
| 2017 | 60.5% | CN¥3.56 Billion | CN¥5.88 Billion | CN¥2.32 Billion | ▲ +4.8 pp |
| 2016 | 55.7% | CN¥3.52 Billion | CN¥6.32 Billion | CN¥2.80 Billion | ▲ +7.4 pp |
| 2015 | 48.3% | CN¥3.02 Billion | CN¥6.26 Billion | CN¥3.23 Billion | ▼ -5.5 pp |
| 2014 | 53.8% | CN¥3.21 Billion | CN¥5.97 Billion | CN¥2.76 Billion | ▲ +5.9 pp |
| 2013 | 47.9% | CN¥2.94 Billion | CN¥6.14 Billion | CN¥3.20 Billion | ▼ -23.3 pp |
| 2012 | 71.2% | CN¥3.17 Billion | CN¥4.45 Billion | CN¥1.28 Billion | ▼ -19.0 pp |
| 2011 | 90.2% | CN¥2.71 Billion | CN¥3.01 Billion | CN¥293.62 Million | ▲ +4.8 pp |
| 2010 | 85.4% | CN¥2.55 Billion | CN¥2.99 Billion | CN¥435.52 Million | ▲ +40.2 pp |
| 2009 | 45.2% | CN¥174.69 Million | CN¥386.12 Million | CN¥211.43 Million | ▲ +12.7 pp |
| 2008 | 32.6% | CN¥98.36 Million | CN¥301.90 Million | CN¥203.54 Million | ▲ +24.5 pp |
| 2007 | 8.1% | CN¥17.66 Million | CN¥217.52 Million | CN¥199.86 Million | — |